NOTE SETTLEMENT AGREEMENTNote Settlement Agreement • August 11th, 2020 • Generex Biotechnology Corp • Pharmaceutical preparations • Utah
This Note Settlement Agreement (this “Agreement”) is entered into as of July 31, 2020 (the “Effective Date”) by and between Iliad Research and Trading, L.P., a Utah limited partnership (“Lender”), and Generex Biotechnology Corporation, a Delaware corporation (“Borrower”). Capitalized terms used in this Agreement without definition shall have the meanings given to them in the Note (defined below). Each of Borrower and Lender is sometimes referred to herein individually as a “Party” and collectively as the “Parties.”
